APA (7th ed.) Citation

Y, L., LR, H., Y, G., NN, Z., Y, L., XK, Z., . . . D, X. (2019). CHD1L contributes to cisplatin resistance by upregulating the ABCB1-NF-κB axis in human non-small-cell lung cancer. Cell death & disease, 10(2), 99. https://doi.org/10.1038/s41419-019-1371-1

Chicago Style (17th ed.) Citation

Y, Li, et al. "CHD1L Contributes to Cisplatin Resistance by Upregulating the ABCB1-NF-κB Axis in Human Non-small-cell Lung Cancer." Cell Death & Disease 10, no. 2 (2019): 99. https://doi.org/10.1038/s41419-019-1371-1.

MLA (9th ed.) Citation

Y, Li, et al. "CHD1L Contributes to Cisplatin Resistance by Upregulating the ABCB1-NF-κB Axis in Human Non-small-cell Lung Cancer." Cell Death & Disease, vol. 10, no. 2, 2019, p. 99, https://doi.org/10.1038/s41419-019-1371-1.